Literature DB >> 1067858

Endomyocardial fibrosis associated with daunorubicin therapy.

R G Wilcox, P D James, P J Toghill.   

Abstract

A case of endomyocardial fibrosis in a patient with acute myeloblastic leukaemia treated by daunorubicin is reported. The pathological findings are indistinguishable from tropical endomyocardial fibrosis.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1067858      PMCID： PMC483097          DOI： 10.1136/hrt.38.8.860

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  7 in total

1.  Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease.

Authors:  C Y Chew; G M Ziady; M J Raphael; M Nellen; C M Oakley
Journal:  Br Heart J       Date:  1977-04

Review 2.  Eosinophilia and heart disease.

Authors:  C M Oakley; G J Olsen
Journal:  Br Heart J       Date:  1977-03

Review 3.  Drug-induced cardiovascular diseases.

Authors:  S M Deglin; J M Deglin; E K Chung
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

4.  Adriamycin cardiotoxicity: report of an unusual case with features resembling endomyocardial fibrosis.

Authors:  W Fitter; D J deSa; K R Pai
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

5.  Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.

Authors:  F A Bu'Lock; M G Mott; A Oakhill; R P Martin
Journal:  Br Heart J       Date:  1995-04

6.  Assessment of adriamycin cardiotoxicity in children by systolic time intervals.

Authors:  H E Ulmer; R Ludwig; H Geiger
Journal:  Eur J Pediatr       Date:  1979-04-25       Impact factor: 3.183

7.  Transforming growth factor beta 1 induces methylation changes in lung fibroblasts.

Authors:  Miguel Negreros; James S Hagood; Celia R Espinoza; Yalbi I Balderas-Martínez; Moisés Selman; Annie Pardo
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.